CPD: Multi-Modality Approaches for Managing GLP/GIP Side Effects
Aesthetic nurse prescriber Anna Baker discusses multi-modality approaches to addressing tissue changes with glucagon-like peptide-1 agonists and glucose-dependent insulinotropic polypeptide therapies Current literature suggests that medical aesthetic practitioners are noticing